Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 11Brain Neoplasms 11Gliosarcoma 9Neuroblastoma 5Astrocytoma 5Oligodendroglioma 4Glioma 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Sarcoma 3Rhabdomyosarcoma 3Rhabdoid Tumor 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Central Nervous System Neoplasms 3Breast Neoplasms 3Wilms Tumor 2Prostatic Neoplasms 2Osteosarcoma 2Neurofibromatosis 2 2Neurofibromatosis 1 2Neoplasms 2Melanoma 2Medulloblastoma 2Ependymoma 2Carcinoma, Hepatocellular 2Vestibulocochlear Nerve Diseases 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

mirdametinib 3Imatinib Mesylate 3Surveys and Questionnaires 2tipifarnib 1talimogene laherparepvec 1pirfenidone 1nilotinib 1emvododstat 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatoses × Sirolimus × CNS × Clear all
NCT01031901 2012-02-27

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

The University of Texas Health Science Center, Houston

Phase 1 Completed
52 enrolled
CNS

Neurofibroma, Tuberous Sclerosis, Neurofibromatoses, Angiofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡